OC-0051 Quality of Life After Radical Radiotherapy for Prostate Cancer: Results from a Randomised Trial of Ebrt ± HDR-BT (original) (raw)

Quality of Life (QoL) after radical radiotherapy for prostate cancer was evaluated through a randomized trial comparing External Beam Radiotherapy (EBRT) alone and EBRT combined with High-Dose Rate Brachytherapy (HDR-BT). Results indicate that while the combination therapy improved biochemical control, it did not significantly reduce QoL as measured by FACT-P and FACT-G scores. Notably, erectile function scores were slightly lower in the combined therapy group but did not show significant deterioration over time. The additional diagnostic value of 11 C-choline PET-CT in tumor localization was found to be limited when used alongside multiparametric MRI.